Early Results from a Biomarker-Directed Phase 2 Trial of Sy-1425 in Combination with Azacitidine or Daratumumab in Non-APL Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Cook, RJ; Moyo, T; Liesveld, JL; Rizzieri, DA; Stein, EM; De Botton, S; Roboz, GJ; Sekeres, MA; Jurcic, JG; Raza, A; Redner, RL; Bixby, DL; Cortes, JE; Stephens, K; Volkert, A; Kang, Q; Di Tomaso, E; Roth, DA; Vigil, CE

Published Date

  • November 29, 2018

Published In

Volume / Issue

  • 132 /

Published By


  • 4

Electronic International Standard Serial Number (EISSN)

  • 1528-0020

International Standard Serial Number (ISSN)

  • 0006-4971

Digital Object Identifier (DOI)

  • 10.1182/blood-2018-99-111285

Conference Name

  • 60th Annual Meeting of the American-Society-of-Hematology (ASH)

Conference Location

  • San Diego, CA

Conference Start Date

  • December 1, 2018

Conference End Date

  • December 4, 2018